We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Green Tea Saves the Brain in Stroke

By HospiMedica staff writers
Posted on 09 Feb 2007
A basic compound found in every cell in the body and in an extract of green tea may prevent brain damage caused from stroke, according to two new studies.

In the first study, researchers at the San Francisco Veterans' Affairs (VA) Medical Center (SFVAMC, CA, USA) subjected rats' brains to ischemia for two hours in a model of stroke. More...
The researchers then administered nicotinamide adenine dinucleotide (NAD+) intranasally immediately after reperfusion (the time when stroke damage actually occurs, since brain cells are suddenly exposed to highly reactive, toxic, and unstable oxygen molecules). The researchers found that NAD+ reduced brain cell death from reperfusion by 70-86% compared with rats not given the treatment. The study was published in the January 1, 2007, issue of Frontiers in Bioscience.

NAD+ plays a number of essential roles in cell metabolism. One role is supporting the activity of the DNA repair enzyme poly (adenosine diphosphate-ribose) polymerase (PARP-1), which normally repairs cell damage from brain infection. In response to reperfusion following ischemia or brain trauma, PARP-1 is overactivated, quickly depleting all available NAD+, and is consequently unable to repair cell damage, leading to brain cell death.

In the second study, by the same team of researchers, green tea extract gallotannin (GT) showed similar results to NAD+, reducing brain cell death significantly when administered intranasally up to three hours after reperfusion. GT has been shown to inhibit the action of the enzyme poly (adenosine diphosphate-ribose) glycohydrolase (PARG) - an enzyme closely related to PARP-1 - and in doing so decrease cell death under ischemia-like conditions. The study also showed that GT provided no protection at all against either PARG or apoptosis inducing factor (AIF) when administered intravenously (IV). The results of the study were reported at the 2006 annual meeting of the American Society for Neurosciences, held in Atlanta (GA, USA) during October 2006.

Our experimental results have suggested that NAD+ can produce greater protective effects than GT against ischemia,” said lead author of both studies Weihei Ying, Ph.D., a research scientist at SFVAMC and an assistant adjunct professor of neurology at the University of California, San Francisco (UCSF, USA). "Plus, NAD+ is a fundamental molecule for cell metabolism, so it is known to have relatively low toxicity.”



Related Links:
San Francisco veterans affairs (VA) Medical Center
University of California, San Francisco

Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.